Personal profile
Fingerprint
Dive into the research topics where Shiri Shulman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort Study
Yanai, H., Achler, T., Ben-Tov, A., Sharar Fischler, T., Patalon, T., Gazit, S., Assa, A. & Shulman, S., 1 Feb 2026, In: Inflammatory Bowel Diseases. 32, 2, p. 220-227 8 p.Research output: Contribution to journal › Article › peer-review
-
Real-world evidence of long-term durability and efficacy of faricimab as an advanced treatment line for NVAMD and DME
Galindo, A. M., Ohayon, A., Hod, K., Levin, M. F., Geffen, N. & Shulman, S., 1 Dec 2026, In: International Ophthalmology. 46, 1, 47.Research output: Contribution to journal › Article › peer-review
-
Topical β-blockers for treatment of glaucoma and the risk of Parkinson’s disease
Meshi, A., Giladi, N., Zahavi, A., Gabbay, I. E., Gal-Or, O., Dotan, A., Gazit, S., Patalon, T., Kozlov, Y., Geffen, N. & Shulman, S., 1 Feb 2026, In: British Journal of Ophthalmology. 110, 2, p. 148-154 7 p.Research output: Contribution to journal › Article › peer-review
-
Exposure to air pollutants contributes to increased rate of neovascular age-related macular degeneration in Israel
Sela, A., Levinshtein, R. & Shulman, S., 1 Apr 2025, In: PLOS ONE. 20, 4 April, e0317436.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
New design peripheral defocus spectacle lens vs. single-vision for slowing myopia progression in children: randomized controlled trial
Wygnanski-Jaffe, T., Shulman, S., Gottesman, N., Feit, N., Corcos, Y., Zvibach, O. & Stolovitch, C., 1 Dec 2025, In: Scientific Reports. 15, 1, 39861.Research output: Contribution to journal › Article › peer-review
Open Access -
Parkinson’s disease incidence in glaucoma patients from israel: insights from a 20-year follow-up sample
Kozlov, Y., Geffen, N., Shulman, S., Zahavi, A., Gal-Or, O., Dotan, A., Gazit, S., Patalon, T. & Meshi, A., 1 Dec 2025, In: Graefe's Archive for Clinical and Experimental Ophthalmology. 263, 12, p. 3471-3481 11 p.Research output: Contribution to journal › Article › peer-review
-
The Prevalence and Characteristics of Inflammatory Bowel Disease-related Ocular Involvement in Children
Ben-Tov, A., Achler, T., Patalon, T., Gazit, S., Yanai, H., Shulman, S. & Assa, A., 1 May 2025, In: Inflammatory Bowel Diseases. 31, 5, p. 1256-1262 7 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Use of immunomodulatory treatment for noninfectious uveitis: an International Ocular Inflammation Society report of real-world practice
International Study Group for Systemic Immunomodulatory Drug Treatment of Non-Infectious Uveitis, 1 Apr 2025, In: British Journal of Ophthalmology. 109, 4, p. 482-489 8 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Anti-vascular endothelial growth factor treatment in diabetic macular edema: Results from a large single-center cohort with bevacizumab as first-line therapy
Zur, D., Hod, K., Trivizki, O., Rabinovitch, D., Schwartz, S. & Shulman, S., 1 Aug 2024, In: Retina. 44, 8, p. 1305-1313 9 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy
Rabinovitch, D., Shulman, S., Goldenberg, D., Wang, L., Iyer, P., Loewenstein, A., Igra, N., Levine, O., Herrera, G. & Trivizki, O., 1 Dec 2024, In: Biomedicines. 12, 12, 2760.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations